Absolute Quantification.
Seamless Proteomics.
NEW PRODUCT:
DiscoveryEdge™175
Includes 177 biologically relevant protein targets:
- Apolipoproteins
- Complement proteins
- Coagulation factors
- Inflammatory markers
- Metabolism related proteins
- Cancer markers
- …and more
Unique concept for MS-based quantification
Bringing precision into absolute quantification
for next generation blood profiling
Vision
Bringing precision into absolute proteome quantification for next generation blood profiling.
Mission
Providing an analytical platform for state-of-the-art accuracy for absolute protein quantification using mass spectrometry.
Our Story
ProteomEdge™ is a company from Stockholm, Sweden, started by researchers at the Human Protein Atlas program (www.proteinatlas.org) and the national infrastructure Science for Life Laboratory (www.scilifelab.se).
The company is developing proprietary analysis platforms based on mass spectrometry to offer labeled protein standards for a wide range of protein targets of both clinical and research interest.
The first product – ApoEdge™ was launched November 1, 2023.
DiscoveryEdge™175 – a product to explore more than 175 protein targets – was released in April, 2024
